DUBLIN--(BUSINESS WIRE)-- ICON plc (ICLR), (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been rated as one of the top-performing contract research ...

DUBLIN--(BUSINESS WIRE)-- ICON plc (ICLR), (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured in the first half of 2025 with a number of ...

We recently compiled a list of the Top 8 Trending AI Stock Updates On Wall Street Today. In this article, we are going to take a look at where ICON Public Limited Company (NASDAQ:ICLR) stands against ...

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today releases its ICON Cares 2024 Report. The report outlines how ...

Baron Funds, an investment management company, released its “Baron Small Cap Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. In the second quarter of 2025, the ...

In February of last year, Icon said it would “vigorously” defend a US lawsuit that stated company insiders had “motive and opportunity to defraud investors” when they sold almost $78 million worth of ...

DUBLIN--(BUSINESS WIRE)-- ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation, today announced that it will release its financial results for the third quarter 2025 after the ...

The Clinical Trials industry is set to achieve significant growth, projecting a value of US$ 99.25 Billion by 2033 from US$ 61.93 Billion in 2025, at a CAGR of 6.07%. This surge is driven by an ...

ICON PLC was scheduled to report fourth-quarter earnings Wednesday, but investors will have to wait until at least late April for results as the clinical research organization navigates an internal ...